News
1h
Zacks Investment Research on MSN4 Low-Beta Defensive Stocks to Buy as Rate Cut Uncertainty ContinuesThe uncertainty over the timing of the next rate cut persists as the Federal Reserve is still maintaining a cautious stance, with policymakers concerned about the inflationary pressures that are going ...
MP Materials (MP) was a big mover last session on higher-than-average trading volume. The latest trend in earnings estimate ...
Delta Air Lines ( DAL - Free Report) came out with quarterly earnings of $2.1 per share, beating the Zacks Consensus Estimate of $2.04 per share. This compares to earnings of $2.36 per share a year ...
Cadence (CADE) has been upgraded to a Zacks Rank #1 (Strong Buy), reflecting growing optimism about the company's earnings prospects. This might drive the stock higher in the near term.
Here are three stocks with buy rank and strong income characteristics for investors to consider today, July 10th: Repsol ...
Detailed price information for Abbott Laboratories (ABT-N) from The Globe and Mail including charting and trades.
Momentum investing revolves around the idea of following a stock's recent trend in either direction. In the 'long' context, investors will be essentially be "buying high, but hoping to sell even ...
2d
Zacks Investment Research on MSNHow to Find Strong Buy Medical Stocks Using the Zacks RankIt doesn't matter if you're a growth, value, income, or momentum-focused investor -- building a successful investment portfolio takes skill, research, and a little bit of luck. But what's the best way ...
For the most recent quarter, Northern Trust was expected to post earnings of $1.9 per share, but it reported $1.85 per share ...
Wall Street analysts remain bullish on Eli Lilly, boasting an Average Brokerage Recommendation (ABR) of 1.46, largely between ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results